References
- Archived: WHO Timeline - COVID-19 [Internet]. [accessed 2021 May 15]. https://www.who.int/news/item/27-04-2020-who-timeline—covid-19
- WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data [Internet]. [accessed 2021 Apr 26]. https://covid19.who.int/
- Atalan A. Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Ann Med Surg (Lond). 2020;56:38–42. doi:10.1016/j.amsu.2020.06.010.
- Lotfi M, Hamblin MR, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254–66. doi:10.1016/j.cca.2020.05.044.
- Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86:140–46. doi:10.2471/blt.07.040089.
- Plotkin S. History of vaccination. Proc Natl Acad Sci USA. 2014;111:12283–87.
- Han S. Clinical vaccine development. Clin Exp Vaccine Res. 2015;4:46–53. doi:10.7774/cevr.2015.4.1.46.
- Vaccines – COVID19 vaccine Tracker [Internet] [accessed 2021 May 15]. https://covid19.trackvaccines.org/vaccines/
- Covid-19 vaccine tracker: latest updates - The New York Times [Internet]. [accessed 2021 May 15]. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
- Coronavirus (COVID-19) vaccinations - statistics and research [Internet]. Our World Data [accessed 2021 May 13]. https://ourworldindata.org/covid-vaccinations
- Delany I, Rappuoli R, De Gregorio E. Vaccines for the 21st century. EMBO Mol Med. 2014;6:708–20. doi:10.1002/emmm.201403876.
- Commissioner O of the. COVID-19 vaccines. FDA [Internet]; 2021 [accessed 2021 May 15]. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines
- Ministério da Saúde. Plano Nacional de Operacionalização da Vacinação Contra a COVID-19 [Internet]. [accessed 2021 May 15]. https://www.gov.br/saude/pt-br/vacinacao
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15. doi:10.1056/NEJMoa2034577.
- Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2020;384:403–416.NEJMoa2035389. doi:10.1056/NEJMoa2035389.
- Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. 2021;397(10275):671–81. doi:10.1016/S0140-6736(21)00234-8.
- Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021;397:99–111. doi:10.1016/S0140-6736(20)32661-1.
- Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19. N Engl J Med. 2021. [epub ahead of print]. doi:10.1056/NEJMoa2101544
- Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–92. doi:10.1016/S1473-3099(20)30843-4.
- Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, Singh K, Yadav D, Sharma P, Misra S. Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin Biochem. 2021. [epub ahead of print]. doi:10.1007/s12291-021-00968-z.
- Funk CD, Laferrière C, Ardakani A. Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond: an early 2021 perspective. Viruses. 2021;13:418. doi:10.3390/v13030418.
- Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, et al. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021. [epub ahead of print]. doi:10.1016/S1473-3099(21)00127-4
- Combate à epidemia de H1N1: um histórico de sucesso. CEE Fiocruz [Internet]. [accessed 2021 May 13]. https://cee.fiocruz.br/?q=node/1314
- Vacinas: uso emergencial [Internet]. Agência Nac. Vigilância Sanitária - Anvisa [accessed 2021 May 15]. https://www.gov.br/anvisa/pt-br/assuntos/paf/coronavirus/vacinas-covid/vacinas-uso-emergencial
- Plano Nacional de Operacionalização da Vacinação contra Covid-19 [Internet]. Minist. Saúde [accessed 2021 May 15]. https://www.gov.br/saude/pt-br/coronavirus/vacinas/plano-nacional-de-operacionalizacao-da-vacina-contra-a-covid-19
- Áreas Territoriais | instituto Brasileiro de Geografia e Estatística (IBGE) [Internet] [accessed 2021 May 15]. https://www.ibge.gov.br/geociencias/organizacao-do-territorio/estrutura-territorial/15761-areas-dos-municipios.html?=&t=o-que-e.
- IBGE | portal do Instituto Brasileiro de Geografia e Estatística (IBGE) | IBGE [Internet] [accessed 2021 May 15]. https://www.ibge.gov.br/cidades-e-estados.
- IBGE | portal do Instituto Brasileiro de Geografia e Estatística (IBGE) | IBGE [Internet]. [accessed 2021 May 15]. https://www.ibge.gov.br/explica/pib.php.
- Localiza SUS [Internet] [accessed 2021 May 15]. https://localizasus.saude.gov.br/
- Palamim CVC, Marson FAL. COVID-19 – the Availability of ICU Beds in Brazil during the Onset of Pandemic. Ann Glob Health. 2020;86:100. doi:10.5334/aogh.3025.
- Largest countries in the world | statista [Internet] [accessed 2021 May 15]. https://www.statista.com/statistics/262955/largest-countries-in-the-world/
- dos Santos M, Stur E, Maia LL, Agostini LP, Peterle GT, Mendes SO, Tajara EH, de Carvalho MB, Louro ID, Silva-Conforti AM. Genetic variability of inflammatory genes in the Brazilian population. Genet Test Mol Biomarkers. 2013;17:844–48. doi:10.1089/gtmb.2013.0264.
- Relatórios de Pesquisa | saúde Amanhã [Internet] [accessed 2021 May 19]. https://saudeamanha.fiocruz.br/relatorios-de-pesquisa/#.YKV8QahKhik
- De Albuquerque MV, d’Ávila VAL, De Lima LD, Ferreira MP, Fusaro ER, Iozzi FL. Desigualdades regionais na saúde: mudanças observadas no Brasil de 2000 a 2016. Ciênc Saúde Coletiva. 2017;22:1055–64. doi:10.1590/1413-81232017224.26862016.
- Mendes MF, Pereira LR, Lima TM, Melani VF, Palamim CVC, Boschiero MN, Marson FAL. COVID-19 pandemic evolution in the Brazilian Indigenous population. J Racial Ethn Health Disparities. 2021. [online ahead of print]. doi:10.1007/s40615-021-01031-6.
- Da Silva NN, Favacho VBC, de Boska GA, da Andrade EC, Das Merces NP, de Oliveira MAF, Da Silva NN, Favacho VBC, de Boska GA, da Andrade EC, et al. Acesso da população negra a serviços de saúde: revisão integrativa. Rev Bras Enferm. 2020;73:e20180834. doi:10.1590/0034-7167-2018-0834.
- Analfabetismo - Ministério da Educação [Internet] [accessed 2021 May 15]. http://portal.mec.gov.br/component/tags/tag/34167
- Cutler DM, Lleras-Muney A. Understanding differences in health behaviors by education. J Health Econ. 2010;29:1–28. doi:10.1016/j.jhealeco.2009.10.003.
- Palamim CVC, Ortega MM, Marson FAL. COVID-19 in the indigenous population of Brazil. J Racial Ethn Health Disparities. 2020;7:1053–58. doi:10.1007/s40615-020-00885-6.
- Cupertino GA, Do Cupertino MC, Gomes AP, Braga LM, Siqueira-Batista R. COVID-19 and Brazilian indigenous populations. Am J Trop Med Hyg. 2020;103:609–12. doi:10.4269/ajtmh.20-0563.
- Davy C, Harfield S, McArthur A, Munn Z, Brown A. Access to primary health care services for Indigenous peoples: a framework synthesis. Int J Equity Health. 2016;15:163. doi:10.1186/s12939-016-0450-5.
- Aspin C, Brown N, Jowsey T, Yen L, Leeder S. Strategic approaches to enhanced health service delivery for Aboriginal and Torres Strait Islander people with chronic illness: a qualitative study. BMC Health Serv Res. 2012;12:143. doi:10.1186/1472-6963-12-143.
- Brancalion PHS, Broadbent EN, De-miguel S, Cardil A, Rosa MR, Almeida CT, Almeida DRA, Chakravarty S, Zhou M, Gamarra JGP, et al. Emerging threats linking tropical deforestation and the COVID-19 pandemic. Perspect Ecol Conserv. 2020;18:243–46. doi:10.1016/j.pecon.2020.09.006.
- Saúde Indígena [Internet]. [accessed 2021 May 15]. http://www.saudeindigena.net.br/coronavirus/mapaEp.php
- Chen S-L, Yu H, Luo H-M, Wu Q, Li C-F, Steinmetz A. Conservation and sustainable use of medicinal plants: problems, progress, and prospects. Chin Med. 2016;11:37. doi:10.1186/s13020-016-0108-7.
- Lins TC, Vieira RG, Abreu BS, Grattapaglia D, Pereira RW. Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs. Am J Hum Biol Off J Hum Biol Counc. 2010;22:187–92. doi:10.1002/ajhb.20976.
- Walker RS, Sattenspiel L, Hill KR. Mortality from contact-related epidemics among indigenous populations in Greater Amazonia. Sci Rep. 2015;5:14032.
- Massey E A sermon against the dangerous and sinful practice of inoculation. Preach’d at St. Andrew’s Holborn, on Sunday, July the 8th, 1722./By Edmund Massey, M.A. Lecturer of St. Alban Woodstreet. [Internet]; 2008. http://name.umdl.umich.edu/N02782.0001.001
- Hussain A, Ali S, Ahmed M, Hussain S. The anti-vaccination movement: a regression in modern medicine. Cureus. 2018;10:e2919. doi:10.7759/cureus.2919.
- Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet. 1998;351:637–41. doi:10.1016/s0140-6736(97)11096-0.
- Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, Waight PA. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. The Lancet. 1999;353:2026–29. doi:10.1016/s0140-6736(99)01239-8.
- Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001;108:E58. doi:10.1542/peds.108.4.e58.
- Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine. 2001;19:3632–365. doi:10.1016/s0264-410x(01)00097-4.
- Imunizações - Taxa de Abandono - Brasil [Internet]. [accessed 2021 May 15]. http://tabnet.datasus.gov.br/cgi/dhdat.exe?bd_pni/tpnibr.def
- Andamento da análise das vacinas na Anvisa [Internet]. Agência Nac. Vigilância Sanitária - Anvisa [accessed 2021 May 15]. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2020/andamento-da-analise-das-vacinas-na-anvisa.
- Boschiero MN, Palamim CVC, Marson FAL. COVID-19 vaccination on Brazil and the crocodile side-effect. Ethics Med Public Health. 2021;17:100654. doi:10.1016/j.jemep.2021.100654.
- Portal da Câmara dos Deputados [Internet] [accessed 2021 May 17]. https://www.camara.leg.br/proposicoesWeb/fichadetramitacao?idProposicao=2274204
- Compra de vacina por empresas: projeto de lei na Câmara enfraquece Anvisa e SUS, dizem especialistas [Internet]. G1 [accessed 2021 May 17]. https://g1.globo.com/bemestar/vacina/noticia/2021/04/07/nova-lei-de-compra-de-vacina-pela-iniciativa-privada-enfraquece-anvisa-e-e-inutil-a-vacinacao-nacional-dizem-especialistas.ghtml
- Dubé E, Gagnon D, MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. 2015;33:4191–203. doi:10.1016/j.vaccine.2015.04.041.
- Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013;31:4293–304. doi:10.1016/j.vaccine.2013.07.013.
- Weigmann K. An injection of confidence: scientists explore new and old methods to counter anti-vaccine propaganda and overcome vaccine hesitancy so as to increase vaccination rates. EMBO Rep. 2017;18:21–24. doi:10.15252/embr.201643589.
- Malta M, Strathdee SA, Garcia PJ. The Brazilian tragedy: where patients living at the ‘Earth’s lungs’ die of asphyxia, and the fallacy of herd immunity is killing people. EClinicalMedicine. 2021;32:100757. doi:10.1016/j.eclinm.2021.100757.
- Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein - SARS-CoV-2 coronavirus/nCoV-2019 Genomic Epidemiology [Internet]. Virological; 2021 [accessed 2021 May 18]. https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585
- Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings - SARS-CoV-2 coronavirus/nCoV-2019 Genomic Epidemiology [Internet]. Virological; 2021 [accessed 2021 May 18]. https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586
- Sabino EC, Buss LF, Carvalho MPS, Prete CA Jr, Crispim MAE, Fraiji NA, Pereira RHM, Parag KV, da Silva Peixoto P, Kraemer MUG, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet. 2021;397:452–55. doi:10.1016/S0140-6736(21)00183-5.
- Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, Bloom JD. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021;29:463–476.e6. doi:10.1016/j.chom.2021.02.003.
- Mais de 16 mil brasileiros tomaram doses trocadas da vacina contra covid: quais são os riscos? [Internet]. BBC News Bras. [accessed 2021 May 15]. https://www.bbc.com/portuguese/brasil-57033107
- About Com-COV2 [Internet]. [accessed 2021 May 15]. about-com-cov2
- Ledford H. Could mixing COVID vaccines boost immune response? Nature. 2021;590:375–76. doi:10.1038/d41586-021-00315-5.
- Yang J, Zheng W, Shi H, Yan X, Dong K, You Q, Zhong G, Gong H, Chen Z, Jit M, et al. Who should be prioritized for COVID-19 vaccination in China? A descriptive study. BMC Med. 2021;19:45. doi:10.1186/s12916-021-01923-8.
- Jung J. Preparing for the Coronavirus disease (COVID-19) Vaccination: evidence, Plans, and Implications. J Korean Med Sci. 2021;36:e59. doi:10.3346/jkms.2021.36.e59.
- PROADI-SUS - Conheça os princípios do SUS, que garantem democratização da saúde brasileira [Internet]. PROADI-SUS - Conheça Os Princípios SUS Que Garantem Democr. Saúde Bras [accessed 2021 May 18]. https://hospitais.proadi-sus.org.br/noticias/130/conheca-os-principios-do-sus-que-garantem-democratizacao-da-saude-brasileira
- Domingues CMAS, Maranhão AGK, Teixeira AM, Fantinato FFS, Domingues RAS, Domingues CMAS, Maranhão AGK, Teixeira AM, Fantinato FFS, Domingues RAS. The Brazilian national immunization program: 46 years of achievements and challenges. Cad Saúde Pública. 2020;36:e00222919. doi:10.1590/0102-311X00222919.
- Domingues CMAS, da Teixeira AMS. Coberturas vacinais e doenças imunopreveníveis no Brasil no período 1982-2012: avanços e desafios do Programa Nacional de Imunizações. Epidemiol Serv Saúde. 2013;22:9–27. doi:10.5123/S1679-49742013000100002.
- SINANWEB - Dados Epidemiológicos Sinan [Internet]. [accessed 2021 May 19]. http://portalsinan.saude.gov.br/dados-epidemiologicos-sinan
- WHO, World Health Organization. Monitoring vaccine wastage at country level : guidelines for programme managers; 2005 [accessed 2021 May 15]. https://apps.who.int/iris/handle/10665/68463
- Yoo BK, Holland ML, Bhattacharya J, Phelps CE, Szilagyi PG. Effects of Mass media coverage on timing and annual receipt of Influenza vaccination among medicare elderly. Health Serv Res. 2010;45(5Pt1):1287–309. doi:10.1111/j.1475-6773.x2010.01127.x.
- Nacional I RESOLUÇÃO RDC No 475, DE 10 DE Março DE 2021 - DOU - Imprensa Nacional [Internet]. [accessed 2021 May 17]. https://www.in.gov.br/web/dou
- Agência Nacional de Vigilância Sanitária - Anvisa [Internet]. [accessed 2021 May 17]. https://webcache.googleusercontent.com/search?q=cache:rfy9Cg_s_0kJ:https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/medicamentos/publicacoes-sobre-medicamentos/guia-sobre-os-requisitos-minimos-para-submissao-de-solicitacao-de-autorizacao-temporaria-de-uso-emergencial-em-carater-experimental-de-vacinas-covid-19+&cd=1&hl=pt-BR&ct=clnk&gl=br
- Registros [Internet]. Agência Nac. Vigilância Sanitária - Anvisa [accessed 2021 May 15]. https://www.gov.br/anvisa/pt-br/assuntos/paf/coronavirus/vacinas-covid/registros
- UK medicines regulator gives approval for first UK COVID-19 vaccine [Internet]. GOV.UK [accessed 2021 May 15]. https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine
- CPI da COVID: governo Bolsonaro recusou 11 vezes ofertas para compras de vacina [Internet]. G1 [accessed 2021 May 16]. https://g1.globo.com/politica/blog/octavio-guedes/post/2021/04/27/cpi-da-covid-governo-bolsonaro-recusou-11-vezes-ofertas-para-compras-de-vacina.ghtml
- Não acompanhou a CPI da Covid? Veja o que rolou até aqui [Internet]. G1 [accessed 2021 May 16]. https://g1.globo.com/politica/noticia/2021/05/15/cpi-da-covid-principais-pontos.ghtml
- Coronavirus (COVID-19) vaccine [Internet]. nhs.uk2020 [accessed 2021 May 17]. https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/
- Boschiero MN, Palamim CVC, Ortega MM, Mauch RM, Marson FAL. One year of Coronavirus disease 2019 (COVID-19) in Brazil: a political and social overview. Ann Glob Health. 2021;87:44. doi:10.5334/aogh.3182.